Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
During this time, more hair may enter a resting phase, which can lead to increased shedding
Medras ZJ, El-Sayed NM, Zaitone SA, Toraih EA, Sami MM, Moustafa YM
The Journal of Clinical Endocrinology & Metabolism 105, e2695e2709
A quick visit sorts it out with pricing and packages confirmed up front
available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference
